Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP

Apollo Hospitals Enterprise — Q4 FY2020 Earnings Presentation

27 slides from Apollo Hospitals Enterprise's earnings presentation, Jan 15, 2021

  1. Slide 1: Q4 FY 2020 Earnings Update

    Q4 FY 2020 Earnings Update 1/15/2021 www.apollohospitals.com 1

  2. Slide 2: Safe Harbour

    SAFE HARBOUR • No representation or warranty, express or implied, is made as to, and no additional information. These are not to be construed as being provided reliance should be placed on, the fairness, accuracy, completeness or under any legal or regulatory requirements. The accuracy of these numb

  3. Slide 3: Contents

    Contents OPERATIONAL UPDATE ON STANDALONE CONSOLIDATED OPERATIONAL AHLL & PERFORMANCE HIGHLIGHTS FINANCIAL FINANCIAL PERFORMANCE GLENEAGLES – STANDALONE PERFORMANCE PERFORMANCE – HOSPITALS KOLKATA PHARMACY 3 1/15/2021 www.apollohospitals.com 3

  4. Slide 4: Highlights

    HIGHLIGHTS 4 1/15/2021 www.apollohospitals.com 4

  5. Slide 5: Highlights of Financial Performance FY20

    Highlights 1 of 2  FY20 Consolidated Revenues of ` 112,468 mio (up 17% yoy)  FY20 Consolidated EBITDA (Pre Ind AS 116) of ` 12,880 mio (up 21% yoy) Financial  New Hospitals (excluding Proton) reported an EBITDA of ` 917 mio in FY20 as compared to an EBITDA ` 604 mio in FY19. Performance  Proton

  6. Slide 6: Highlights: Capacity and Medical Initiatives

    Highlights 2 of 2  71 hospitals with total bed capacity of 10,261 beds as on Mar 31, 2020  45 owned hospitals including JVs/ Subsidiaries and Associates with 8,822 beds Capacity  11 Day care/ short surgical stay centres with 270 beds and 10 Cradles with 260 beds.  5 Managed hospitals with 909 be

  7. Slide 7: Ind AS 116 Impact Analysis

    IND AS 116 IMPACT ANALYSIS 1/15/2021 www.apollohospitals.com 7

  8. Slide 8: Impact on P&L and Balance Sheet – FY20

    Impact on P&L and Balance Sheet – FY20 (` mio) Ind AS 116 was effective 1st April 2019 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 12,891 Revenue - Right of use 16,463 Revenue - Asset Asset Other expenses

  9. Slide 9: Standalone Financial Performance

    STANDALONE FINANCIAL PERFORMANCE 9 1/15/2021 www.apollohospitals.com 9

  10. Slide 10: Standalone Financial Performance – Total

    Standalone Financial Performance – Total (` mio) 1 of 3 Q4 FY 19 Q4 FY 20 yoy (%) FY 19 FY 20 yoy (%) Revenue 21,671 25,721 18.7% 83,367 97,944 17.5% Key Highlights Operative Expenses 11,262 13,956 23.9% 43,690 51,820 18.6% Employee Expenses 3,474 3,930 13.1% 12,951 15,192 17.3% FY20 Revenues of ` 9

  11. Slide 11: Standalone Financial Performance – Mature & New Breakup

    Standalone Financial Performance – Mature & New Breakup (` mio) 2 of 3 Healthcare Healthcare Key Highlights Service New Services SAP Standalone (Mature) Hospitals Proton (Total) Health Care Services revenue growth Hospitals 22 10 1 33 at 11.8% from ` 44,506 mio in FY 19 to Operating beds 3,359 1,489

  12. Slide 12: Standalone Financial Performance – Segment Reporting

    Standalone Financial Performance – Segment Reporting (` mio) 3 of 3 Q4 FY 19 Q4 FY 20 yoy (%) FY 19 FY 20 yoy (%) Revenues from each segment Key Highlights Healthcare Services* 11,489 12,138 5.6% 44,514 49,746 11.8% Stand-alone Pharmacy 10,184 13,585 33.4% 38,860 48,206 24.1% FY20 Healthcare service

  13. Slide 13: Consolidated Financial Performance

    CONSOLIDATED FINANCIAL PERFORMANCE 13 1/15/2021 www.apollohospitals.com 13

  14. Slide 14: Consolidated Financial Performance – Total

    Consolidated Financial Performance - Total (` mio) 1 of 2 Key Highlights Q4 FY 19 Q4 FY 20 yoy (%) FY 19 FY 20 yoy (%) Total Revenues 24,995 29,224 16.9% 96,174 112,468 16.9% Revenue growth of 16.9% from ` 96,174 mio in FY19 to ` 112,468 mio EBITDA (Pre Ind AS 116) 2,796 2,989 6.9% 10,637 12,880 21.

  15. Slide 15: Consolidated Financial Performance – Mature & New Breakup

    Consolidated Financial Performance – Mature & New Breakup – Total (` mio) 2 of 2 Healthcare Healthcare Healthcare Serv Serv Serv Key Highlights Group Proton SAP AHLL Consol Group Group (New & (Mature) (Total) AHLL – Cradle & Clinics reported positive Others) EBITDA of ` 18 mio as compared to loss Ho

  16. Slide 16: Operational Performance Hospitals

    OPERATIONAL PERFORMANCE HOSPITALS 16 1/15/2021 www.apollohospitals.com 16

  17. Slide 17: Operational Performance – Hospitals (1/2)

    Operational Performance – Hospitals (1/2) (` mio) Tamilnadu Region AP, Telengana Region Total (8) (Chennai & others) (1) (Hyderabad & others) (2) Particulars FY 19 FY 20 yoy (%) FY 19 FY 20 yoy (%) FY 19 FY 20 yoy (%) No. of Operating beds 7,246 7,491 2,121 2,208 1,344 1,344 Inpatient volume 4,51,89

  18. Slide 18: Operational Performance – Hospitals (2/2)

    Operational Performance – Hospitals (2/2) (` mio) Karnataka Region Significant Subs/JVs/associates Others (4) (Bangalore & others) (3) (5) Particulars FY 19 FY 20 yoy (%) FY 19 FY 20 yoy (%) FY 19 FY 20 yoy (%) No. of Operating beds 746 769 910 962 2,125 2,208 Inpatient volume 52,382 55,881 6.7% 65,

  19. Slide 19: Operational Performance Standalone Pharmacy

    OPERATIONAL PERFORMANCE STANDALONE PHARMACY 19 1/15/2021 www.apollohospitals.com 19

  20. Slide 20: Operational Performance – Standalone Pharmacy

    Operational Performance – Standalone Pharmacy (` mio) Batch Particulars Q4 FY 19 Q4 FY 20 yoy (%) FY 19 FY 20 yoy (%) Key Highlights No of Stores 1106 1075 1106 1075 FY20 Revenues at ` 48,206 mio, growth of Revenue/store 3.90 4.64 19.0% 15.68 17.41 11.0% 24.1% Upto FY 12 Batch EBITDA /store 0.32 0.4

  21. Slide 21: Update on Apollo Health & Lifestyle & Gleneagles Kolkata

    UPDATE ON APOLLO HEALTH & LIFESTYLE & GLENEAGLES KOLKATA 21 1/15/2021 www.apollohospitals.com 21

  22. Slide 22: Update on AHLL

    Update on AHLL (` mio) Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) Spectra (IP) Network 148 650 25 64 42 12 15 Key Highlights Footfalls/Day* 2229 5075 542 162 602 51 80 Gross ARPP (Rs.)* 1715 549 2377 6696 1373 74819 78849 Gross Revenue growth of 18%, primarily driven by 28% growth in Dia

  23. Slide 23: Update on Gleneagles Kolkata

    Update on Gleneagles Kolkata (` mio) Apollo Gleneagles Kolkata Particulars Q4 FY 19 Q4 FY 20 yoy (%) FY 19 FY 20 yoy (%) Key Highlights Total Income 1,166 1,155 -0.9% 4,327 4,670 7.9% Apollo Gleneagles Kolkata reported Revenue of EBITDA (Pre OMA fees to ` 4,670 mio in FY20, 7.9% growth partners)* 20

  24. Slide 24: Appendix

    24 1/15/2021 www.apollohospitals.com 24

  25. Slide 25: Appendix: Basis of Consolidation

    Appendix: Basis of Consolidation AHEL AHEL AHEL Standalone Location Description Subsidiaries Location Description Ownership Ownership Samudra Healthcare Enterprises Ltd. Kakinada Hospital 100.00% Chennai Main Chennai Hospital Apollo Hospitals (UK) Ltd UK Hospital 100.00% ACI - Chennai Chennai Hospit

  26. Slide 26: Hospitals – Understanding Key Operating Metrics

    Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver Operating Beds • Number of operating beds • Project execution • Capital Expenditure Occupancy • In-patient Bed Days • In-patient Bed Days Billed • Brand • Doctor reputation • Quality of outcomes • Competitio

  27. Slide 27: Thank You

    THANK YOU 27 1/15/2021 www.apollohospitals.com 27

Apollo Hospitals Enterprise — Q4 FY2020 Earnings Presentation on 6ix